Events

EU Missions Info Days
JAN
Tue
18
JAN
Wed
19

This was 3 years ago

Location

Online

Programmes
Health Climate, Energy, Mobility Agro-Food, Environment Missions

The European Commission has announced dedicated Info-Days for the EU Missions to inform potential applicants and stakeholders about the new topics included in the updated EU Missions work programme 2021.

The Info-Days will present a wide range of new topics for all five missions (Adaptation to Climate Change, Restore our Ocean and Waters by 2030, A Soil Deal for Europe, Cancer and 100 Climate-Neutral and Smart cities by 2030) which are part of the amended Missions’ Work Programme 2021 under Horizon Europe. 

The Commission invites researchers and innovators as well as citizens and all interested stakeholders to take part in the five missions.

For a detailed agenda, participation information and practical details, visit the event website.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.